Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
종목 코드 VTAK
회사 이름Catheter Precision Inc
상장일Sep 27, 2018
설립일2018
CEOMr. David A. Jenkins
직원 수22
유형Ordinary Share
회계 연도 종료Sep 27
주소1670 Highway 160 West
도시FORT MILL
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호29708
전화19736912000
웹사이트https://www.ramed.com/
종목 코드 VTAK
상장일Sep 27, 2018
설립일2018
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음